104 related articles for article (PubMed ID: 3317325)
21. [Enzyme-linked immunosorbent assay for serum prostate specific antigen (PSA) using monoclonal antibodies].
Setoguchi C; Matsumoto K; Samori T; Kimura E; Harukaze S
Rinsho Byori; 1998 Jan; 46(1):79-82. PubMed ID: 9492543
[TBL] [Abstract][Full Text] [Related]
22. [Treatment monitoring, recurrence detection, prognosis. Here's where tumor markers make good sense].
Lamerz R; Stieber P
MMW Fortschr Med; 2002 Oct; 144(41):26-8, 30-2. PubMed ID: 12474357
[TBL] [Abstract][Full Text] [Related]
23. Serum tumor markers.
Perkins GL; Slater ED; Sanders GK; Prichard JG
Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
[TBL] [Abstract][Full Text] [Related]
24. Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies.
Colcher D; Minelli MF; Roselli M; Muraro R; Simpson-Milenic D; Schlom J
Cancer Res; 1988 Aug; 48(16):4597-603. PubMed ID: 3396011
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies (Mabs) in head and neck cancer.
Poliquin JF; Filion LG
J Otolaryngol; 1986 Oct; 15(5):289-92. PubMed ID: 3534285
[TBL] [Abstract][Full Text] [Related]
26. Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers.
Müller M; Meyer M; Schilling T; Ulsperger E; Lehnert T; Zentgraf H; Stremmel W; Volkmann M; Galle PR
Int J Oncol; 2006 Oct; 29(4):973-80. PubMed ID: 16964393
[TBL] [Abstract][Full Text] [Related]
27. [Clinical importance of serum anti-p53 antibodies as tumor markers].
Sakai H; Okamoto E
Rinsho Byori; 2002 Oct; 50(10):970-5. PubMed ID: 12451677
[TBL] [Abstract][Full Text] [Related]
28. Challenges in cancer research and multifaceted approaches for cancer biomarker quest.
Martinkova J; Gadher SJ; Hajduch M; Kovarova H
FEBS Lett; 2009 Jun; 583(11):1772-84. PubMed ID: 19327356
[TBL] [Abstract][Full Text] [Related]
29. [Detection of carbohydrate antigens of malignant cells in sputum with panel of monoclonal antibodies].
Kimura S; Saito D; Hakomori S; Matsuto T; Sugita O; Himeji Y; Akamatsu S; Okada M
Rinsho Byori; 1993 Jun; 41(6):649-54. PubMed ID: 8361031
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies in diagnostic dermatopathology.
Cerio R; MacDonald DM
Adv Dermatol; 1988; 3():123-40. PubMed ID: 3152816
[No Abstract] [Full Text] [Related]
31. [Cytokeratin tumor markers in ovarian carcinoma: tissue polypeptide specific antigen (TPS) and M3/M21].
Hefler L; Tempfer C; Häusler G; Heinzl H; Kainz C
Wien Klin Wochenschr; 1998 Oct; 110(18):635-41. PubMed ID: 9816636
[TBL] [Abstract][Full Text] [Related]
32. [Monoclonal antibodies in oncology: applications in diagnosis, prognosis and prediction of response to therapy on tissue specimens].
Penault-Llorca FM; Balaton AJ
Bull Cancer; 2000 Nov; 87(11):794-803. PubMed ID: 11125288
[TBL] [Abstract][Full Text] [Related]
33. [Contemporary molecular-biological methods of cancer diagnosis and monitoring based on the humoral immune response to tumor-associated antigens].
Shebzukhov IuV; Belousov PV; Khlgatian SV; Sazykin AIu; Kuprash DV; Nedospasov SA
Mol Gen Mikrobiol Virusol; 2007; (2):3-6. PubMed ID: 17600920
[TBL] [Abstract][Full Text] [Related]
34. The application of monoclonal antibodies in cancer diagnosis.
Zhang X; Soori G; Dobleman TJ; Xiao GG
Expert Rev Mol Diagn; 2014 Jan; 14(1):97-106. PubMed ID: 24308340
[TBL] [Abstract][Full Text] [Related]
35. [Status quo of tumor markers and important points in medical practice].
Shimetani N
Rinsho Byori; 2003 Dec; 51(12):1216-20. PubMed ID: 14743745
[TBL] [Abstract][Full Text] [Related]
36. [Improvement of total prostate specific antigen(PSA) assay from the "Skewed molar-response" to the "Equimolar-response" by utilizing anti free-PSA monoclonal antibodies].
Kimura E; Matsumoto K; Samori T
Rinsho Byori; 2002 Feb; 50(2):202-6. PubMed ID: 11925860
[TBL] [Abstract][Full Text] [Related]
37. The use of mucin-specific monoclonal antibodies and lectins in the detection of tumor-associated serum markers in gynecological cancer.
Devine PL; McGuckin MA; Ramm LE; Harada H; Ward BG
Cancer Biochem Biophys; 1993 Sep; 13(4):221-38. PubMed ID: 8521372
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibodies for early cytologic detection of lung cancer.
Shaw GL; Mulshine JL
Semin Thorac Cardiovasc Surg; 1993 Jul; 5(3):201-9. PubMed ID: 8353148
[No Abstract] [Full Text] [Related]
39. Molecular optical imaging of therapeutic targets of cancer.
Sokolov K; Nida D; Descour M; Lacy A; Levy M; Hall B; Dharmawardhane S; Ellington A; Korgel B; Richards-Kortum R
Adv Cancer Res; 2007; 96():299-344. PubMed ID: 17161684
[TBL] [Abstract][Full Text] [Related]
40. [Immunohistochemical tumor diagnosis--possibilities and limitations].
Brandtzaeg P
Tidsskr Nor Laegeforen; 1994 Aug; 114(20):2386-91. PubMed ID: 7527942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
